Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1ME9

Inosine Monophosphate Dehydrogenase (IMPDH) From Tritrichomonas Foetus with IMP bound

Summary for 1ME9
Entry DOI10.2210/pdb1me9/pdb
Related1AK5 1ME7 1ME8 1MEH 1MEI 1MEW
DescriptorINOSINE-5'-MONOPHOSPHATE DEHYDROGENASE, POTASSIUM ION, INOSINIC ACID, ... (4 entities in total)
Functional Keywordsalpha beta barrel, oxidoreductase
Biological sourceTritrichomonas foetus
Total number of polymer chains1
Total formula weight55943.32
Authors
Prosise, G.L.,Luecke, H. (deposition date: 2002-08-08, release date: 2003-08-12, Last modification date: 2024-11-06)
Primary citationProsise, G.L.,Luecke, H.
Crystal Structures of Tritrichomonas foetus Inosine Monophosphate Dehydrogenase in Complex with Substrate, Cofactor and Analogs: A Structural Basis for the Random-in Ordered-out Kinetic Mechanism
J.Mol.Biol., 326:517-527, 2003
Cited by
PubMed Abstract: The enzyme inosine monophosphate dehydrogenase (IMPDH) is responsible for the rate-limiting step in guanine nucleotide biosynthesis. Because it is up-regulated in rapidly proliferating cells, human type II IMPDH is actively targeted for immunosuppressive, anticancer, and antiviral chemotherapy. The enzyme employs a random-in ordered-out kinetic mechanism where substrate or cofactor can bind first but product is only released after the cofactor leaves. Due to structural and kinetic differences between mammalian and microbial enzymes, most drugs that are successful in the inhibition of mammalian IMPDH are far less effective against the microbial forms of the enzyme. It is possible that with greater knowledge of the structural mechanism of the microbial enzymes, an effective and selective inhibitor of microbial IMPDH will be developed for use as a drug against multi-drug resistant bacteria and protists. The high-resolution crystal structures of four different complexes of IMPDH from the protozoan parasite Tritrichomonas foetus have been solved: with its substrate IMP, IMP and the inhibitor mycophenolic acid (MPA), the product XMP with MPA, and XMP with the cofactor NAD(+). In addition, a potassium ion has been located at the dimer interface. A structural model for the kinetic mechanism is proposed.
PubMed: 12559919
DOI: 10.1016/S0022-2836(02)01383-9
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.2 Å)
Structure validation

229183

건을2024-12-18부터공개중

PDB statisticsPDBj update infoContact PDBjnumon